GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
LINGO2 | 21207 | HTM/LTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA and Transcriptomics followed by RT-PCR and Western Blotting | NA | 0.52 | 0.0011 | 30696080
|
NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5461 | 30284938
|
POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.6448 | 30284938
|
SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5695 | 30284938
|
CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by IF staining | NA | 0.24 | 1 | 30284938
|
ABCF2 | 71 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
ABCF2 | 71 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
ABCF2 | 71 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
ABCF2 | 71 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
ADAM22 | 201 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ADGRB3 | 945 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
AHNAK2 | 20125 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
AKAP12 | 370 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
AMH | 464 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
ANO3 | 14004 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
ARHGAP29 | 30207 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
ARL4C | 698 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
ARMCX3 | 24065 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ARSD | 717 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ASNS | 753 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
BCL11A | 13221 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
BIRC3 | 591 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
C15ORF48 | 29898 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
CALB1 | 1434 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
CALD1 | 1441 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
CAV1 | 1527 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 30696080
|
CAV2 | 1528 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080
|
CBX5 | 1555 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
CCL5 | 10632 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080
|
CCND1 | 1582 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0201 | 30696080
|
CD24 | 1645 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.456 | 30696080
|
CD36 | 1663 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
CD55 | 2665 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
CDH19 | 1758 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
CDKN2AIPNL | 30545 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
CEP350 | 24238 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
CFAP44 | 25631 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
CFAP70 | 30726 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
CHGB | 1930 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
CLDN1 | 2032 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
CLIC3 | 2064 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
CLU | 2095 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080
|
CNTNAP3 | 13834 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
COL1A1 | 2197 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
COL21A1 | 17025 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
COTL1 | 18304 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
CPE | 2303 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080
|
CRYZL1 | 2420 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
CSMD3 | 19291 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
CXCL1 | 4602 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080
|
CYR61 | 2654 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
DDIT4 | 24944 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
DHX9 | 2750 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080
|
DKK3 | 2893 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
DNER | 24456 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
DOCK10 | 23479 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
DPY19L2 | 19414 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
DSC1 | 3035 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
DST | 1090 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
DTNA | 3057 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
EDN3 | 3178 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
EFEMP1 | 3218 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080
|
EGFR | 3236 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080
|
EMP1 | 3333 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
EMP3 | 3335 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
EPHA5 | 3389 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ETS1 | 3488 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
F2R | 3537 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
F2RL1 | 3538 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
FAT4 | 23109 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
FGF2 | 3676 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
FH | 3700 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
FHL2 | 3703 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
FOLR1 | 3791 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080
|
FOXF1 | 3809 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
FSTL3 | 3973 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
FZD7 | 4045 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 30696080
|
GADD45B | 4096 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
GEM | 4234 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
GIGYF2 | 11960 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
GPATCH2 | 25499 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
GRAMD2B | 24911 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080
|
GRK6 | 4545 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
HGF | 4893 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
HOMER1 | 17512 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
ID2 | 5361 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 30696080
|
ID2B | 30656 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ID4 | 5363 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080
|
IGF1 | 5464 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080
|
IGFBP6 | 5475 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
IL8 | 6025 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 30696080
|
ITGA2 | 6137 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 30696080
|
JAM2 | 14686 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
KAZN | 29173 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
KCNN4 | 6293 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
KDR | 6307 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
KLF5 | 6349 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
KLHL1 | 6352 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
KMT5B | 24283 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
LAMP3 | 14582 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
LIPA | 6617 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
LMO3 | 6643 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
LONP2 | 20598 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
LOX | 6664 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080
|
LRATD2 | 24166 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
LRFN5 | 20360 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
LRRN3 | 17200 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
LY6E | 6727 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
MALAT1 | 29665 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 30696080
|
MDFIC | 28870 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
MICAL2 | 24693 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
MICB | 7091 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
MMP1 | 7155 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
MSL1 | 27905 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
MUC15 | 14956 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
MYO10 | 7593 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
MZF1 | 13108 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
NABP1 | 26232 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
NAV2 | 15997 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
NAV3 | 15998 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
NCEH1 | 29260 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
NEBL | 16932 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
NEXMIF | 29433 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
NLGN1 | 14291 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
NNMT | 7861 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
NOX4 | 7891 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
NREP | 16834 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
NT5E | 8021 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0095 | 30696080
|
NUCB2 | 8044 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
P2RY1 | 8539 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
PALLD | 17068 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
PAPPA | 8602 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
PCDH9 | 8661 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
PDLIM7 | 22958 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
PHLDA1 | 8933 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
PHLDA2 | 12385 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
PLAG1 | 9045 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
PLAU | 9052 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
PLGLA | 9074 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
PLXDC2 | 21013 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
POSTN | 16953 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080
|
PROCR | 9452 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
PROSER2 | 23728 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
PRPS1 | 9462 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
PRSS23 | 14370 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
PSAT1 | 19129 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
PSMB9 | 9546 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
PTK2 | 9611 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
PTPRK | 9674 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
QKI | 21100 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
RAB31 | 9771 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
RBM24 | 21539 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SAMD9 | 1348 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SAT1 | 10540 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080
|
SCIN | 21695 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
SCUBE3 | 13655 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
SDC2 | 10659 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080
|
SELENOP | 10751 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
SERPINB2 | 8584 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
SGK1 | 10810 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
SGSH | 10818 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
SH3BP4 | 10826 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
SLC16A6 | 10927 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SLC6A15 | 13621 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SNCA | 11138 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SOCS3 | 19391 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SOX9 | 11204 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0244 | 30696080
|
SPHK1 | 11240 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SPOCK1 | 11251 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
SPX | 28139 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
SRPX | 11309 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
SWAP70 | 17070 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
SYCP2 | 11490 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080
|
TFAP2C | 11744 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
THBS1 | 11785 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080
|
TM4SF1 | 11853 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080
|
TNS3 | 21616 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080
|
TOX2 | 16095 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
TRIM73 | 18162 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
TRIP10 | 12304 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080
|
ULBP2 | 14894 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080
|
XXYLT1 | 26639 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080
|
ZMAT1 | 29377 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|
ZNF436 | 20814 | HTM | Gastric Cancer | Adenocarcinoma | SNU484 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080
|